Skip to main content

News
Features
Voices
Education
Your Journey
Subscribe

The FNAIT Journey: Living

Find out what’s new and what’s next in treatment options for FNAIT.

Diagnosis Seekers
Newly Diagnosed
On Your Way
Long-Term Living

Treatments New method may help predict platelet transfusion risk in infants
Science Antibodies differ in patients with platelet transfusion refractoriness
Science Researchers identify potential treatment for neonatal brain bleed
Treatments Clinical trial to test nipocalimab vs IVIG to prevent FNAIT
Immune thrombocytopenia in late pregnancy requires specialized care
Science Alloimmunization risk factors include genetics and immune system
Science Why FNAIT can affect siblings differently

Previous page Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 … Page 10 Next page Last page

Learn more about FNAIT

Sign up for the latest news, perspectives, and information about FNAIT.

Your news and information resource for fetal and neonatal alloimmune thrombocytopenia

Search for:

News
Features
Voices
Education
Contribute
About
Staff

Part of the Haymarket Medical Network

Rare Disease Companion (RDC) is a network of news and information websites that supports people living with rare diseases. Through accurate, authentic, and compassionate news coverage, feature-length articles, and patient-friendly educational material, RDC provides insights into living with rare diseases at every point along the patient journey.

Copyright © 2026 Haymarket Media, Inc. All Rights Reserved. This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media’s Privacy Policy and Terms & Conditions.